preloader

News

All
Funding research
Science news

BIG’s Annual Report 2017 now available

27-06-2018

Brussels, Belgium – 27 June 2018. BIG is pleased to present the latest Annual Report 2017. Thanks to your support and the continuous dedi

lisez plus

OUTCOME BIG’S EXECUTIVE BOARD ELECTIONS

05-06-2018

Following BIG’s General Assembly (GA), we are very happy to announce the outcome of the BIG Executive Board (EB) elections.

lisez plus

Grossesse après un cancer du sein : l'étude BIG Time for Baby fait des progrès

10-05-2018

BIG Time for Baby progresse : déjà 234 patientes participent à l'étude et plus que 20 bébés sont nés en bonne santé.

lisez plus

FONDATION ARC LÉOPOLD GRIFFUEL AWARD FOR TRANSLATIONAL AND CLINICAL RESEARCH

13-04-2018

"The prize is a wonderful recognition for the dedication and work of our teams at BIG and at the Jules Bordet Institute" says Prof. Piccart.

lisez plus

1 OUT OF 3 MEN WITH BREAST CANCER DOES NOT RECEIVE ADEQUATE TREATMENT

02-02-2018

Researchers confirm the poor quality of care for men affected by breast cancer and urge for a clinical trial.

lisez plus

BIG’s Annual Report 2016 now available

26-07-2017

We are pleased to present our latest Annual Report and are very proud of the continuous dedication and hard work of BIG’s now 59 collabora

lisez plus

New Executive Board appointed

03-07-2017

BIG against breast cancer is pleased to announce the election of its new Executive Board. It will go into effect from 1 July 2017.

lisez plus

BIG time for baby: 100+ patients enrolled

05-04-2017

The international and purely academic POSITIVE study has already recruited more than 100 patients from 113 activated hospitals and cancer ce

lisez plus

Dr. M. Piccart to receive the “2017 St. Gallen International Breast Cancer Award”

10-03-2017

Foundation SONK is honouring Professor Martine Piccart for her extraordinary clinical research contribution in the advancement of early, cur

lisez plus

MINDACT Trial - 46% of patients could be spared from unnecessary chemotherapy

10-07-2016

The first results of the MINDACT trial, using the MammaPrint® test, have just been presented and give hope to many women with early-stage b

lisez plus